These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17651715)

  • 1. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
    Cheng CW; Yu JC; Wang HW; Huang CS; Shieh JC; Fu YP; Chang CW; Wu PE; Shen CY
    Clin Chim Acta; 2010 Feb; 411(3-4):234-41. PubMed ID: 19914229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.
    Yorishima T; Nagai N; Ohama K
    Hiroshima J Med Sci; 1997 Mar; 46(1):21-9. PubMed ID: 9114564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations associated with early stages of breast tumor metastasis.
    Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
    Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
    Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
    J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of alternative splicing markers for breast cancer.
    Venables JP; Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Koh C; Gervais-Bird J; Lapointe E; Froehlich U; Durand M; Gendron D; Brosseau JP; Thibault P; Lucier JF; Tremblay K; Prinos P; Wellinger RJ; Chabot B; Rancourt C; Elela SA
    Cancer Res; 2008 Nov; 68(22):9525-31. PubMed ID: 19010929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer.
    Watanabe O; Kinoshita J; Shimizu T; Imamura H; Hirano A; Okabe T; Aiba M; Ogawa K
    J Exp Clin Cancer Res; 2005 Mar; 24(1):75-82. PubMed ID: 15943035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.